References
- American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J. Am. Ger. Soc.57 , 1331–1346 (2009).
- Antman EM , BennettJS, DaughertyA, FurbergC, RobertsH, Taubert KA; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation115(12) , 1634–1642 (2007).
- Pergolizzi J , AloisiAM, DahanA et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 10 , 428–450 (2010).
- Kress HG . Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur. J. Pain13 , 219–230 (2009).
- Griessinger N , SittlR, LikarR. Transdermal buprenorphine in clinical practice – a post-marketing surveillance study in 13,179 patients. Curr. Med. Res. Opin.21 , 1147–1156 (2005).
- Muriel C , FaildeI, MicóJA, NeiraM, Sánchez-MagroI. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin. Ther.27 , 451–462 (2005).
- Vadivelu N , HinesRL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin. Interv. Aging3 , 421–430 (2008).
- Pergolizzi J , BögerRH, BuddK et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8 , 287–313 (2008).
- Muriel Villoria C , Perez-Castejon Garotte JM, Sanchez Magro I, Neira Alvarez I. Effectiveness and safety of transdermal buprenorphine for chronic pain treatment in the elderly: a prospective observational study. Med. Clin.128(6) , 204–210 (2007).
- Przeklasa-Muszynska A , DobrogowskiJ. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland. Curr. Med. Res. Opin.27 , 1109–1117 (2011).
▪ Website
- Grünenthal GmbH. Transtec 35, 52.5 and 70 micrograms per hour transdermal patch – summary of product characteristics. www.grunenthal.com/cms/cda/_common/inc/display_file.jsp?fileID=9400035